Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Antibiotics (Basel, Switzerland)|August 26, 2022
The Effect of Different Colistin Dosing Regimens on Nephrotoxicity: A Cohort StudyMichael Samarkos, Konstantinos Papanikolaou, Athena Sourdi, et al.
Foodborne Pathogens and Disease|September 9, 2009
Prevalence and characterization of class 1 integrons in Escherichia coli of poultry and human originAlexandra Vasilakopoulou, Mina Psichogiou, Leonidas Tzouvelekis, et al.
Annals of Gastroenterology|January 12, 2016
Systemic levels of human β-defensin 1 are elevated in patients with cirrhosisGaryfallia Kaltsa, Giorgos Bamias, Spyros I Siakavellas, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2009
Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infectionsGeorge L Daikos, Panayiotis Petrikkos, Mina Psichogiou, et al.
Infectious Diseases and Therapy|July 6, 2023
Clinical and Economic Value of Reducing Antimicrobial Resistance in the Management of Hospital-Acquired Infections with Limited Treatment Options in GreeceMyrto Barmpouni, Jason P Gordon, Ryan L Miller, et al.
Diagnostic Microbiology and Infectious Disease|May 23, 2017
Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcomePolydoros Tofas, Michael Samarkos, Evangelia-Theophano Piperaki, et al.
Journal of Chemotherapy (Florence, Italy)|October 9, 2012
Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, GreeceIrene Galani, Maria Souli, George L Daikos, et al.
Diagnostic Microbiology and Infectious Disease|December 14, 2007
Evolution of macrolide resistance in Streptococcus pneumoniae clinical isolates in the prevaccine eraGeorge L Daikos, Anastasia Koutsolioutsou, Sotirios Tsiodras, et al.
Angiology|September 22, 2018
Prevalence, Incidence, and Contributors of Subclinical Atheromatosis, Arteriosclerosis, and Arterial Hypertrophy in HIV-Infected Individuals: A Single-Center, 3-Year Prospective StudyMina Psichogiou, Chris J Kapelios, Giorgos Konstantonis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2020
Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing EnterobacteralesMarco Falcone, George L Daikos, Giusy Tiseo, et al.
Pageof 11